Travere Therapeutics Inc (TVTX)

04:32 AM

Will Travere Therapeutics Inc. stock remain a Wall Street favoriteEarnings Performance Report & Verified Swing Trading Watchlist - ulpravda.ru

04:32 AM

Jan 08, 2026

How Travere Therapeutics Inc. stock performs in weak economyOil Prices & Real-Time Market Sentiment Reports - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will Travere Therapeutics Inc. stock maintain momentum in 2025Bear Alert & Verified Chart Pattern Signals - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How Travere Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Why Travere Therapeutics Inc. stock could benefit from AI revolutionMarket Trend Summary & Technical Buy Zone Confirmations - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

J.P. Morgan Healthcare Conference - MarketScreener

Jan 08, 2026

Jan 07, 2026

Travere Therapeutics (TVTX) CMO logs Rule 10b5-1 and tax-cover share sales - Stock Titan

Jan 07, 2026

Jan 06, 2026

Travere Therapeutics TVTX stock slides 5% as FDA decision on Filspari nears - TechStock²

Jan 06, 2026

Jan 06, 2026

Star TribuneTravere Therapeutics, Inc.Common Stock (Nasdaq:TVTX) Price Chart - FinancialContent

Jan 06, 2026

Jan 06, 2026

Travere Therapeutics, Inc.Common Stock (NQ: TVTX - FinancialContent

Jan 06, 2026

Jan 06, 2026

How Travere Therapeutics Inc. stock reacts to bond yields2026 world cup usa national team round of 16 goalkeepers possession football tactical prediction breakdown - ulpravda.ru

Jan 06, 2026

Jan 05, 2026

Travere Therapeutics (NASDAQ:TVTX) Stock Price Down 6.1%Time to Sell? - MarketBeat

Jan 05, 2026

Jan 05, 2026

Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - MarketScreener

Jan 05, 2026

Jan 05, 2026

Travere Therapeutics Inc (NASDAQ:TVTX) Shows Strong Technical and Fundamental Momentum for Growth Investors - Chartmill

Jan 05, 2026

Jan 03, 2026

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date - ts2.tech

Jan 03, 2026

Jan 03, 2026

Price-Driven Insight from (TVTX) for Rule-Based Strategy - Stock Traders Daily

Jan 03, 2026

Dec 30, 2025

Travere Therapeutics (NASDAQ:TVTX) Stock Price Down 4% Following Insider Selling - MarketBeat

Dec 30, 2025

Dec 30, 2025

Travere Therapeutics, Inc.'s (NASDAQ:TVTX) Shift From Loss To Profit - 富途牛牛

Dec 30, 2025

Dec 30, 2025

Travere Therapeutics Insider Sold Shares Worth $2,406,180, According to a Recent SEC Filing - MarketScreener

Dec 30, 2025

Dec 29, 2025

Travere Therapeutics (NASDAQ:TVTX) Insider Peter Heerma Sells 4,980 Shares - MarketBeat

Dec 29, 2025

Dec 29, 2025

Inrig Jula, chief medical officer of Travere, sells $630,004 in TVTX - Investing.com Canada

Dec 29, 2025

Dec 29, 2025

Travere therapeutics (TVTX) SVP Calvin sells $296k in stock By Investing.com - Investing.com Canada

Dec 29, 2025

Dec 29, 2025

Travere therapeutics (TVTX) chief research officer sells $2.4m in stock - Investing.com Canada

Dec 29, 2025

Dec 29, 2025

Heerma, Travere therapeutics CCO, sells $199k in TVTX stock By Investing.com - Investing.com Canada

Dec 29, 2025

Dec 29, 2025

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CAO Sells 7,402 Shares of Stock - MarketBeat

Dec 29, 2025

Dec 29, 2025

Travere Therapeutics Executives Sell Shares - TradingView — Track All Markets

Dec 29, 2025

Dec 27, 2025

Why Travere Therapeutics stock popped by nearly 14% on Wednesday - MSN

Dec 27, 2025

Dec 27, 2025

Travere Therapeutics Earnings Notes - Trefis

Dec 27, 2025

Dec 26, 2025

Travere Therapeutics Inc. (TVTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 26, 2025

Dec 26, 2025

Traders Buy Large Volume of Call Options on Travere Therapeutics (NASDAQ:TVTX) - MarketBeat

Dec 26, 2025

Dec 26, 2025

Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally - ts2.tech

Dec 26, 2025

Dec 26, 2025

Voya Investment Management LLC Acquires 27,133 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat

Dec 26, 2025

Dec 25, 2025

Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge? - Yahoo Finance

Dec 25, 2025

Dec 25, 2025

Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom - Yahoo Finance

Dec 25, 2025

Dec 25, 2025

Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI - Yahoo! Finance Canada

Dec 25, 2025

Dec 25, 2025

Travere Stock (+14%): FDA Catalyst Speculation Ignites Rally - Trefis

Dec 25, 2025

Dec 24, 2025

Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday - Finviz

Dec 24, 2025

Dec 24, 2025

Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday - The Motley Fool

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics Inducement Grants: Market Anticipations - StocksToTrade

Dec 24, 2025

Dec 24, 2025

Is Travere Therapeutics Stock a Hidden Gem? - timothysykes.com

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics stock gains as FDA messaging on proteinuria endpoint boosts Filspari approval hopes - Investing.com Australia

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets - ts2.tech

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics (TVTX) Shares Surge Over 16% - GuruFocus

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics (TVTX) Surges on Positive FDA Update - GuruFocus

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics Expands with New Employee Stock Grants - timothysykes.com

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics (TVTX) Sees a Significant 13.2% Surge - GuruFocus

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics (NASDAQ:TVTX) Reaches New 52-Week HighHere's Why - MarketBeat

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics stock hits 52-week high at 37.76 USD By Investing.com - Investing.com Nigeria

Dec 24, 2025

Dec 24, 2025

Travere Therapeutics stock hits 52-week high at 37.76 USD - Investing.com

Dec 24, 2025